Ozi ọma!Shanghai Chuangkun Biotech 15 nnukwu ihe ize ndụ HPV nucleic acid ule ngwa (lyophilized, PCR fluorescence usoro), nwetara akwụkwọ ndebanye aha FDA Indonesian!

N'oge na-adịbeghị anya, Shanghai Chuangkun Biotech HPV(15 High- risky subtype) DNA PCR detection kit (lyophilized) nwetara akwụkwọ ndebanye aha FDA nke Indonesia, nke na-egosi na ngwaahịa Chuangkun Biotech bụ ndị Indonesian ghọtara, na-enye nkwado siri ike maka Chuangkun Biotech na-emepe emepe. ahịa mba ụwa.

Dị ka ọnụ ọgụgụ nke World Health Organisation si kwuo, n'afọ 2020, ọrịa cancer cervical na ụwa, ọrịa cancer cervical n'etiti ụbụrụ ụmụ nwanyị na-ebute ụzọ nke anọ mgbe ọrịa cancer akpa ume, ọrịa ara ara na cancer colorectal.N'ụwa niile, ihe dị ka ụmụ nwanyị 500,000 na-ebute ọrịa kansa cervical kwa afọ na ihe dị ka 200,000 na-anwụ site na ọrịa ahụ.Ọrịa kansa cervical bụ naanị ajọ ọrịa etiology a ma ama n'etiti ọrịa ọjọọ mmadụ.egosila na ọrịa papillomavirus mmadụ (HPV) bụ isi ihe na-ebute ọrịa kansa cervical na ọnya ya na-ebute ụzọ (CIN), yana ụdị HPV16 na ụdị 18 na-enye aka karịa 50% nke ọrịa cancer cervical na-ebute ọrịa kansa. Na Nọvemba 17, 2020 , Òtù Ahụ Ike Ụwa (WHO) wepụtara atụmatụ zuru ụwa ọnụ iji mee ka mkpochapụ ọrịa cancer nke cervical, na-ekwusi ike na ọ dị mkpa nyocha nyocha HPV.Na Julaị 6, 2021, WHO kwalitere ma wepụta ụkpụrụ nduzi maka nyocha na ọgwụgwọ nke ọnya ọrịa cervical precancer na cervical. Mgbochi ọrịa kansa, na-atụ aro papillomavirus mmadụ nwere nnukwu ihe ize ndụ (HPV nwere nnukwu ihe ize ndụ) nnwale DNA dị ka usoro nyocha kachasị amasị maka nyocha ọrịa kansa cervical.

Chuangkun Biotech HPV (12+3) DNA PCR detection kit (lyophilized) dabere na multiplex PCR-fluorescent technology technology na dabara adaba maka ngwa PCR chanel anọ.Ngwaahịa ahụ na-anabata usoro mmepụta nke lyophilization niile, na ngwa ahụ nwere ike ibufe ma chekwaa ya na ụlọ okpomọkụ, nke na-edozi isi ihe mgbu nke ụgbọ njem oyi nke mmiri mmiri reagents, ma nwee ike belata ngwa ngwa na njem njem nke ahịa esenidụt.A na-ejikarị ngwaahịa a maka nchọpụta in vitro nke papillomavirus mmadụ na sel exfoliated cervical, na-ekpuchi ụdị ihe ize ndụ 15 dị elu, ma nwee ike ịchọpụta subtypes atọ 16, 18 na 52. Ngwaahịa ahụ nwere njirimara nke mmetụta dị elu (LOD bụ 500 mbipụta / ml). ), nkọwa dị elu, ntinye dị elu na njikwa nrụtụ aka n'ime, wee nabata teknụzụ mgbasawanye na-enweghị mmịpụta na-arụkọ ọrụ na Chuangkun Biotech Thunder usoro ngwa ngwa ihe nchọpụta PCR iji mezue nchọpụta ngwa ngwa nke ihe nlele 16 ~ 96 na nkeji 40, yana Nsonaazụ ziri ezi na ntụkwasị obi.

Nnweta akwụkwọ ndebanye aha FDA Indonesian bụ nnabata zuru oke na nkwenye nke ngwaahịa Chuangkun Biotech.N'ọdịnihu, anyị ga-anọgide na-rapagidesi ike na ahịa-gbakwasara, sayensị na nkà na ụzụ ọhụrụ dị ka nkwado, mgbe niile na-eme ka isi asọmpi nke ụlọ ọrụ, na a zuru ụwa ọnụ ọhụụ na-ewu uru ụdị, site na-adịghị akwụsị akwụsị mgbalị na nnọgidesi ike, iji kwalite mmepe. nke ụlọ ọrụ ahụike, iji nweta nrọ nke ahụike mmadụ ma gbalịsie ike!